EFFECTOR CELL FUNCTION INHIBITOR

摘要

An effector cell function inhibitor comprised of CCR5-antagonist. The effector cell function inhibitor comprised of CCR5-antagonist is capable of inhibiting the function of effector cells playing an important roll in disease generation, etc., so that it is useful in the prevention and/or treatment of, for example, transplant rejections (rejection of solid organ graft, rejection of pancreatic cell transplant in diabetes, graft-versus-host disease (GVHD), etc.), autoimmune diseases (arthritis, chronic arthritic rheumatism, multiple sclerosis, ulcerative colitis, etc.), allergoses (asthma, etc.), ischemic diseases (ischmia reperfusion lesion, etc.), cancer or cancer metabasis, etc.